Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
State-of-the-art document on optimal contemporary management of cardiomyopathies.
Seferović PM, Polovina M, Rosano G, Bozkurt B, Metra M, Heymans S, Mullens W, Bauersachs J, Sliwa K, de Boer RA, Farmakis D, Thum T, Olivotto I, Rapezzi C, Linhart A, Corrado D, Tschöpe C, Milinković I, Bayes Genis A, Filippatos G, Keren A, Ašanin M, Krljanac G, Maksimović R, Skouri H, Ben Gal T, Moura B, Volterrani M, Abdelhamid M, Lopatin Y, Chioncel O, Coats AJS. Seferović PM, et al. Among authors: farmakis d. Eur J Heart Fail. 2023 Nov;25(11):1899-1922. doi: 10.1002/ejhf.2979. Epub 2023 Sep 24. Eur J Heart Fail. 2023. PMID: 37470300 Review.
Levosimendan for the treatment of acute heart failure syndromes.
Parissis JT, Filippatos G, Farmakis D, Adamopoulos S, Paraskevaidis I, Kremastinos D. Parissis JT, et al. Among authors: farmakis d. Expert Opin Pharmacother. 2005 Dec;6(15):2741-51. doi: 10.1517/14656566.6.15.2741. Expert Opin Pharmacother. 2005. PMID: 16316312 Review.
Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure.
Parissis JT, Adamopoulos S, Farmakis D, Filippatos G, Paraskevaidis I, Panou F, Iliodromitis E, Kremastinos DT. Parissis JT, et al. Among authors: farmakis d. Heart. 2006 Dec;92(12):1768-72. doi: 10.1136/hrt.2006.079707. Heart. 2006. PMID: 17105880 Free PMC article. Clinical Trial.
Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure.
Kourea K, Parissis JT, Farmakis D, Panou F, Paraskevaidis I, Venetsanou K, Filippatos G, Kremastinos DT. Kourea K, et al. Among authors: farmakis d. Atherosclerosis. 2008 Jul;199(1):215-21. doi: 10.1016/j.atherosclerosis.2007.09.039. Epub 2007 Nov 7. Atherosclerosis. 2008. PMID: 17991471 Clinical Trial.
Anticoagulants, antiplatelets, and statins in heart failure.
Farmakis D, Filippatos G, Lainscak M, Parissis JT, Anker SD, Kremastinos DT. Farmakis D, et al. Cardiol Clin. 2008 Feb;26(1):49-58, vi. doi: 10.1016/j.ccl.2007.10.001. Cardiol Clin. 2008. PMID: 18312905 Review.
Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT, Kourea K, Panou F, Farmakis D, Paraskevaidis I, Ikonomidis I, Filippatos G, Kremastinos DT. Parissis JT, et al. Among authors: farmakis d. Am Heart J. 2008 Apr;155(4):751.e1-7. doi: 10.1016/j.ahj.2008.01.016. Epub 2008 Mar 6. Am Heart J. 2008. PMID: 18371487 Clinical Trial.
303 results